エピソード

  • NEJM Interview: Christopher Forrest on declines in the health of U.S. children and the role of communities in reversing those trends.
    2026/09/23
    Christopher Forrest is a professor of pediatrics and the director of the Applied Clinical Research Center at Children’s Hospital of Philadelphia. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C.B. Forrest and N. Halfon. Declining Child Health in the United States — Addressing the Developmental Ecosystem. N Engl J Med 2026;395:1147-1149.
    続きを読む 一部表示
    13 分
  • NEJM Interview: Dhruv Khullar on concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory.
    2026/09/16
    Dhruv Khullar is an associate professor of population health sciences and of medicine at Weill Cornell Medical College. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D. Khullar. Artificial Intelligence and the Future of the Clinical Workforce. N Engl J Med 2026;395:1041-1043.
    続きを読む 一部表示
    9 分
  • NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services.
    2026/09/09
    Elizabeth Kaplan is a clinical instructor and the director of health care access at the Center for Health Law and Policy Innovation at Harvard Law School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Kaplan and C. Shachar. The Future of the USPSTF and Evidence-Based Recommendations. N Engl J Med 2026;395:937-939.
    続きを読む 一部表示
    12 分
  • NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion.
    2026/09/02
    Elizabeth Tobin-Tyler is a professor of health services, policy and practice at the Brown University School of Public Health and of family medicine and medical science at Warren Alpert Medical School of Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Tobin-Tyler and G. Chalker. Telehealth Access to Mifepristone — Evaluating Reproductive-Coercion Arguments. N Engl J Med 2026;395:833-835.
    続きを読む 一部表示
    12 分
  • NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research.
    2026/08/19
    Rebecca Haffajee is a professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.L. Haffajee, R.A. Mikos, and Z.D. Cooper. Marijuana Rescheduling — A Game Changer for Research? N Engl J Med 2026;395:729-731.
    続きを読む 一部表示
    13 分
  • NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement.
    2026/08/12
    Eric Schneider is an adjunct professor of health policy and management at the Harvard T.H. Chan School of Public Health and a member of the Journal’s Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Chernew and E.C. Schneider. Rethinking the Role of Pay for Performance in Federal Health Care Quality Programs. N Engl J Med 2026;395:625-628.
    続きを読む 一部表示
    9 分
  • NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness.
    2026/08/05
    Jean Nachega is a professor of infectious diseases and the director of the Biomedical Research Institute at Stellenbosch University and an associate professor at the University of Pittsburgh School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Zumla and Others. Ebola at 50 — Lessons for Outbreak Response and Preparedness. N Engl J Med 2026;395:527-529. S. Tonen-Wolyec and L. Bélec. The Social Contract of Bundibugyo Ebola Isolation. N Engl J Med. DOI: 10.1056/NEJMp2607429.
    続きを読む 一部表示
    11 分
  • NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health.
    2026/07/29
    Jerry Avorn is a professor of medicine at Harvard Medical School and the codirector of the Program on Regulation, Therapeutics, and Law at Harvard Medical School and Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Avorn. Products That Pose Health Risks — Can Litigation Protect Us When Government Fails? N Engl J Med 2026;395:421-423.
    続きを読む 一部表示
    14 分